Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity

Daien, C. I.; Gailhac, S.; Mura, T.; Audo, R.; Combe, B.; Hahne, M.; Morel, J.

Arthritis Rheumatol

2014-08 / vol 66 / pages 2037-46


OBJECTIVE: Regulatory interleukin-10 (IL-10)-producing B cells (B10 cells) have been shown to prevent and cure collagen-induced arthritis in mice. In humans, very little is known about B10 cells in rheumatoid arthritis (RA). Several B cell subsets, such as CD24(high) CD38(high) , CD24(high) CD27+, and CD5+ B cells, were suggested to be precursors of B10 cells. We aimed to analyze these B cell subsets and B10 cells in RA patients and healthy controls. METHODS: B10 cells were generated from peripheral blood mononuclear cells stimulated for 24 hours with CpG and for 4 hours with phorbol 12-myristate 13-acetate/ionomycin/brefeldin A. Intracellular B cell IL-10 was assessed by flow cytometry. Thirty-one controls and 99 RA patients were included. RESULTS: After multiple adjustments, levels of CD24(high) CD38(high) , CD24(high) CD27+, and CD5+ B cells were found to be similar in RA patients and controls. Levels of B10 cells were lower in RA patients than in controls, especially in patients with RA of

Lire sur PubMed


2326-5205 (Electronic)

IGMM team(s) involved in this publication

Toutes les publications